Vanguard Group’s HI-TECH PHARMACAL INC HITK Stock Holding History

Vanguard Group’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-412,652	Closed	-$17.9M	–	4036
2014 Q1	$17.9M	Buy	412,652 +14,193	+4%	+$615K	﹤0.01%	2236
2013 Q4	$17.3M	Buy	398,459 +29,013	+8%	+$1.25M	﹤0.01%	2223
2013 Q3	$15.9M	Buy	369,446 +11,511	+3%	+$441K	﹤0.01%	2199
2013 Q2	$11.9M	Buy	+357,935	New	+$11.9M	﹤0.01%	2258

Vanguard Group's HITK Position: Q2 2014 in Review

Vanguard Group sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 412,652 shares — an estimated $17.9M sold.

Vanguard Group first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $17.9M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Vanguard Group reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Vanguard Group sold 412,652 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $17.9M.
Vanguard Group first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Vanguard Group's HI-TECH PHARMACAL INC position peaked at $17.9M in Q1 2014.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Vanguard Group's 13F filing for Q2 2014, filed 11 Aug 2014.